vs

Side-by-side financial comparison of Grocery Outlet Holding Corp. (GO) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.2B, roughly 1.2× Grocery Outlet Holding Corp.). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs -18.5%, a 22.9% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 10.7%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 8.3%).

Grocery Outlet Holding Corp. is an American discount closeout retailer consisting exclusively of supermarket locations that offer discounted, overstocked, and closeout products from name-brand and private-label suppliers. The company has stores in California, Oregon, Washington, Idaho, Nevada, Maryland, Pennsylvania, New Jersey, Ohio, and Delaware.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

GO vs ONC — Head-to-Head

Bigger by revenue
ONC
ONC
1.2× larger
ONC
$1.5B
$1.2B
GO
Growing faster (revenue YoY)
ONC
ONC
+22.1% gap
ONC
32.8%
10.7%
GO
Higher net margin
ONC
ONC
22.9% more per $
ONC
4.4%
-18.5%
GO
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
8.3%
GO

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
GO
GO
ONC
ONC
Revenue
$1.2B
$1.5B
Net Profit
$-224.9M
$66.5M
Gross Margin
29.7%
90.5%
Operating Margin
12.4%
Net Margin
-18.5%
4.4%
Revenue YoY
10.7%
32.8%
Net Profit YoY
-669.9%
143.8%
EPS (diluted)
$-2.22
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GO
GO
ONC
ONC
Q1 26
$1.2B
Q4 25
$1.5B
Q3 25
$1.2B
$1.4B
Q2 25
$1.2B
$1.3B
Q1 25
$1.1B
$1.1B
Q4 24
$1.1B
$1.1B
Q3 24
$1.1B
$1.0B
Q2 24
$1.1B
$929.2M
Net Profit
GO
GO
ONC
ONC
Q1 26
$-224.9M
Q4 25
$66.5M
Q3 25
$11.6M
$124.8M
Q2 25
$5.0M
$94.3M
Q1 25
$-23.3M
$1.3M
Q4 24
$2.3M
$-151.9M
Q3 24
$24.2M
$-121.3M
Q2 24
$14.0M
$-120.4M
Gross Margin
GO
GO
ONC
ONC
Q1 26
29.7%
Q4 25
90.5%
Q3 25
30.4%
86.1%
Q2 25
30.6%
87.5%
Q1 25
30.4%
85.2%
Q4 24
29.5%
85.8%
Q3 24
31.1%
83.0%
Q2 24
30.9%
85.1%
Operating Margin
GO
GO
ONC
ONC
Q1 26
Q4 25
12.4%
Q3 25
2.0%
11.5%
Q2 25
1.1%
6.7%
Q1 25
-2.0%
1.0%
Q4 24
1.0%
-7.0%
Q3 24
3.6%
-12.0%
Q2 24
2.3%
-11.5%
Net Margin
GO
GO
ONC
ONC
Q1 26
-18.5%
Q4 25
4.4%
Q3 25
1.0%
8.8%
Q2 25
0.4%
7.2%
Q1 25
-2.1%
0.1%
Q4 24
0.2%
-13.5%
Q3 24
2.2%
-12.1%
Q2 24
1.2%
-13.0%
EPS (diluted)
GO
GO
ONC
ONC
Q1 26
$-2.22
Q4 25
$0.05
Q3 25
$0.12
$0.08
Q2 25
$0.05
$0.06
Q1 25
$-0.24
$0.00
Q4 24
$0.03
$-0.10
Q3 24
$0.24
$-0.09
Q2 24
$0.14
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GO
GO
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$69.6M
$4.5B
Total DebtLower is stronger
$15.0M
$836.4M
Stockholders' EquityBook value
$983.7M
$4.4B
Total Assets
$3.1B
$8.2B
Debt / EquityLower = less leverage
0.02×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GO
GO
ONC
ONC
Q1 26
$69.6M
Q4 25
$4.5B
Q3 25
$52.1M
$4.0B
Q2 25
$55.2M
$2.8B
Q1 25
$50.9M
$2.5B
Q4 24
$62.8M
$2.6B
Q3 24
$68.7M
$2.7B
Q2 24
$67.1M
$2.6B
Total Debt
GO
GO
ONC
ONC
Q1 26
$15.0M
Q4 25
$836.4M
Q3 25
$500.3M
Q2 25
$473.9M
Q1 25
$475.7M
Q4 24
$477.5M
Q3 24
$429.3M
Q2 24
$379.2M
Stockholders' Equity
GO
GO
ONC
ONC
Q1 26
$983.7M
Q4 25
$4.4B
Q3 25
$1.2B
$4.1B
Q2 25
$1.2B
$3.8B
Q1 25
$1.2B
$3.5B
Q4 24
$1.2B
$3.3B
Q3 24
$1.2B
$3.4B
Q2 24
$1.2B
$3.4B
Total Assets
GO
GO
ONC
ONC
Q1 26
$3.1B
Q4 25
$8.2B
Q3 25
$3.4B
$7.6B
Q2 25
$3.3B
$6.3B
Q1 25
$3.3B
$5.8B
Q4 24
$3.2B
$5.9B
Q3 24
$3.1B
$5.8B
Q2 24
$3.1B
$5.7B
Debt / Equity
GO
GO
ONC
ONC
Q1 26
0.02×
Q4 25
0.19×
Q3 25
0.42×
Q2 25
0.40×
Q1 25
0.40×
Q4 24
0.40×
Q3 24
0.35×
Q2 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GO
GO
ONC
ONC
Operating Cash FlowLast quarter
$222.1M
$417.3M
Free Cash FlowOCF − Capex
$379.8M
FCF MarginFCF / Revenue
25.4%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
6.28×
TTM Free Cash FlowTrailing 4 quarters
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GO
GO
ONC
ONC
Q1 26
$222.1M
Q4 25
$417.3M
Q3 25
$17.3M
$402.6M
Q2 25
$73.6M
$263.6M
Q1 25
$58.9M
$44.1M
Q4 24
$39.5M
$75.2M
Q3 24
$23.0M
$188.4M
Q2 24
$41.6M
$-95.6M
Free Cash Flow
GO
GO
ONC
ONC
Q1 26
Q4 25
$379.8M
Q3 25
$-21.6M
$354.5M
Q2 25
$14.4M
$219.8M
Q1 25
$-1.5M
$-12.3M
Q4 24
$-19.6M
$-17.3M
Q3 24
$-19.3M
$54.7M
Q2 24
$2.7M
$-205.5M
FCF Margin
GO
GO
ONC
ONC
Q1 26
Q4 25
25.4%
Q3 25
-1.8%
25.1%
Q2 25
1.2%
16.7%
Q1 25
-0.1%
-1.1%
Q4 24
-1.8%
-1.5%
Q3 24
-1.7%
5.5%
Q2 24
0.2%
-22.1%
Capex Intensity
GO
GO
ONC
ONC
Q1 26
Q4 25
2.5%
Q3 25
3.3%
3.4%
Q2 25
5.0%
3.3%
Q1 25
5.4%
5.0%
Q4 24
5.4%
8.2%
Q3 24
3.8%
13.3%
Q2 24
3.4%
11.8%
Cash Conversion
GO
GO
ONC
ONC
Q1 26
Q4 25
6.28×
Q3 25
1.49×
3.22×
Q2 25
14.84×
2.79×
Q1 25
34.71×
Q4 24
17.09×
Q3 24
0.95×
Q2 24
2.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons